Mint-Emtricitabine/Tenofovir 300 mg

MINT-EMTRICITABINE/TENOFOVIR 300 MG tablets combine emtricitabine and tenofovir disoproxil fumarate for HIV treatment. This oral medication is designed to help manage HIV infection in adults and children over 12 years old.

MINT-EMTRICITABINE/TENOFOVIR 300 MG tablets are used as part of antiretroviral therapy (ART) to treat HIV infection. This combination medication helps reduce the amount of HIV in the body, improving immune function and lowering the risk of HIV-related complications. It is typically prescribed alongside other HIV medications to create a comprehensive treatment plan.

Common effects of MINT-EMTRICITABINE/TENOFOVIR 300 MG tablets may include nausea, diarrhea, headache, and dizziness. Some individuals might experience changes in body fat distribution or bone density. It is important to discuss any persistent or severe side effects with a healthcare provider.

MINT-EMTRICITABINE/TENOFOVIR 300 MG tablets should be handled with care. Store at room temperature away from moisture and heat. Follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others.

MINT-EMTRICITABINE/TENOFOVIR 300 MG tablets may interact with other medications, including those used to treat HIV, hepatitis B, or other infections. Alcohol and certain over-the-counter drugs may also affect how this medication works. Always inform your healthcare provider about all medications you are taking.